Easywell Biomedicals, Inc.

1799

TW0001799005

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
74.3 ^TWD	+0.41%		+1.09%	+79.90%

05-08	Easywell Biomedicals, Inc. announced a financing transaction	CI
04-07	Easywell Biomedicals, Inc.'s Subsidiary Jiangsu Huahan Pharma-Tech Co., Ltd. Obtains Approval from the Jiangsu Medical Products Administration of China for Compliance with the Good Manufacturing Practice Inspection for Pharmaceuticals	CI

Easywell Biomedicals, Inc.'s Subsidiary Jiangsu Huahan Pharma-Tech Co., Ltd. Obtains Approval from the Jiangsu Medical Products Administration of China for Compliance with the Good Manufacturing Practice Inspection for Pharmaceuticals

April 07, 2024 at 10:46 am

Easywell Biomedicals, Inc. announced its subsidiary Jiangsu HuaHan Pharma-Tech Co. Ltd. has obtained approval from the Jiangsu Medical Products Administration of China for compliance with the Good Manufacturing Practice (GMP) inspection for pharmaceuticals, enabling it to officially proceed with product manufacturing and sales.

Latest news about Easywell Biomedicals, Inc.

Easywell Biomedicals, Inc. announced a financing transaction	05-07	CI
Easywell Biomedicals, Inc.'s Subsidiary Jiangsu Huahan Pharma-Tech Co., Ltd. Obtains Approval from the Jiangsu Medical Products Administration of China for Compliance with the Good Manufacturing Practice Inspection for Pharmaceuticals	04-07	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	12/05/22	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	12/05/22	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	30/03/22	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	11/11/21	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	12/08/21	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	13/05/21	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	29/03/21	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	11/11/20	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	12/08/20	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	13/05/20	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	29/03/20	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	12/11/19	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	13/08/19	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	13/05/19	CI
Easywell Biomedicals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	27/03/19	CI
Easywell Biomedicals, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018	13/11/18	CI

Chart Easywell Biomedicals, Inc.

Duration

Period

More charts

Company Profile

Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The Company's diagnostic devices include ear thermometers and digital clinical thermometers. The Company distributes its products mainly in Taiwan, the Americas and Europe.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EASYWELL BIOMEDICALS, INC.	+79.90%	278M
ELI LILLY AND COMPANY	+29.67%	682B
NOVO NORDISK A/S	+30.35%	586B
JOHNSON & JOHNSON	-3.60%	364B
MERCK & CO., INC.	+17.71%	327B
ABBVIE INC.	+3.79%	285B
ASTRAZENECA PLC	+15.70%	240B
NOVARTIS AG	+10.32%	209B
ROCHE HOLDING AG	-8.38%	203B
AMGEN INC.	+7.17%	165B